CIK 0001802665
- Large accelerated filer
Harmony Biosciences Holdings, Inc.
Sign in to watch- Ticker
- HRMY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 822279923
- Phone
- +1 484-539-9800
- Business address
- 630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING, PA, 19462
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,108,586
- in 2 filings
Net −$3,108,586. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-16 | Dierks Jeffrey Chief Commercial Officer | Sale | −4,259 | $40.05 | $171K | 0 |
| 2022-02-16 | Dierks Jeffrey Chief Commercial Officer | Exercise or conversion · Stock Option | −4,259 | 140,597 | ||
| 2022-01-06 | Dierks Jeffrey Chief Commercial Officer | Exercise or conversion | +6,125 | $8.22 | $50K | 6,125 |
| 2022-01-06 | Dierks Jeffrey Chief Commercial Officer | Sale | −1,399 | $39.60 | $55K | 4,726 |
| 2022-01-06 | Dierks Jeffrey Chief Commercial Officer | Sale | −4,302 | $40.53 | $174K | 424 |
| 2022-01-06 | Dierks Jeffrey Chief Commercial Officer | Sale | −424 | $41.23 | $17K | 0 |
| 2022-01-06 | Dierks Jeffrey Chief Commercial Officer | Exercise or conversion · Stock Option | −3,690 | 9,739 | ||
| 2022-01-06 | Dierks Jeffrey Chief Commercial Officer | Exercise or conversion · Stock Option | −2,435 | 4,869 | ||
| 2022-01-04 | Jacobs John C President, CEO | Exercise or conversion | +18,053 | $8.22 | $148K | 18,053 |
| 2022-01-04 | Jacobs John C President, CEO | Sale | −18,053 | $45.15 | $815K | 0 |
| 2022-01-04 | Jacobs John C President, CEO | Exercise or conversion · Stock Option | −18,053 | 234,751 | ||
| 2022-01-03 | Jacobs John C President, CEO | Exercise or conversion | +10,647 | $8.22 | $88K | 10,647 |
| 2022-01-03 | Jacobs John C President, CEO | Sale | −10,647 | $45.17 | $481K | 0 |
| 2022-01-03 | Jacobs John C President, CEO | Exercise or conversion · Stock Option | −10,647 | 252,804 | ||
| 2021-12-27 | Jacobs John C President, CEO | Exercise or conversion | +1,300 | $8.22 | $11K | 1,300 |
| 2021-12-27 | Jacobs John C President, CEO | Sale | −1,300 | $45.03 | $59K | 0 |
| 2021-12-27 | Jacobs John C President, CEO | Exercise or conversion · Stock Option | −1,300 | 263,451 | ||
| 2021-12-14 | ARONIN JEFFREY S Director | Exercise or conversion | +251,922 | $24.00 | $6.0M | 251,922 |
| 2021-12-14 | ARONIN JEFFREY S Director | Exercise or conversion · Stock Option | +251,922 | 1,007,689 | ||
| 2021-12-13 | Jacobs John C President, CEO | Exercise or conversion | +25,000 | $8.22 | $206K | 25,000 |
Page 20 of 26 · 511 trades